EUVIMEDEUVIMED entdecken
Crossref

Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway

Zhijun Sun, Min Zhang, Yangmei Ye, Leilei Yang

Hormone and Metabolic Research · 01.05.2024 · 56 (05) · 381-391

DOI: 10.1055/a-2233-0245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.05.2024. Verfasst von Zhijun Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: MicroRNAs, Thyroid Cancer, Papillary, Thyroid Neoplasms, Cell Proliferation. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CircRNAs have been found to participate in the progression of various tumors. In the present study, we aimed to clarify the role of hsa_circ_0092355 in papillary thyroid cancer (PTC) cell development. RT-qPCR was used to determine the expression of hsa_circ_0092355, miR-543, and PDE5A. PTC cell proliferation was ascertained via a cell colony formation assay and the CCK-8 test. Western blotting was performed to examine the expression levels of PDE5A and apoptosis-associated proteins (Bcl-2 and Bax) in PTC cells. A scratch wound assay was performed to measure the migration of PTC cells. A mouse xenograft test was performed to assess the effects of hsa_circ_0092355 in vivo. RIP and dual-luciferase reporter assays confirmed the association between miR-543 and hsa_circ_0092355 or PDE5A. Associations between miR-543, hsa_circ_0092355, and PDE5A were evaluated using Pearson’s correlation coefficient. Upregulation of hsa_circ_0092355 was observed in PTC tissues. The hsa_circ_0092355 knockdown blocked the proliferation and migration of PTC cells and induced apoptosis. Moreover, hsa_circ_0092355 knockdown blocked PTC xenograft tumor growth in vivo. The miR-543 inhibitor could reverse the changes induced by hsa_circ_0092355 knockdown by hsa_circ_0092355 targeting miR-543. Furthermore, miR-543 suppresses PTC progression by downregulating PDE5A expression. Our findings suggest that the PTC tumor promoter hsa_circ_0092355 may promote carcinogenesis by controlling the miR-543/PDE5A pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsThyroid Cancer, PapillaryThyroid NeoplasmsCell ProliferationCyclic Nucleotide Phosphodiesterases, Type 5RNA, CircularGene Expression Regulation, NeoplasticDisease ProgressionHumansAnimalsMiceCell Line, TumorCell MovementMice, NudeMaleFemaleApoptosisSignal TransductionMice, Inbred BALB CMiddle Aged

Substanzen

MicroRNAsCyclic Nucleotide Phosphodiesterases, Type 5RNA, CircularMIR545 microRNA, human

Autor:innen und Institutionen

  • General Surgery Department, Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan, Hubei, China.
  • Nursing Department of General Surgery, Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan, Hubei, China.
  • Pharmacy Department, Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan, Hubei, China.
  • Department of Anesthesiology, Tongren Hospital of Wuhan University, Wuhan Third Hospital, Wuhan, Hubei, China.

Zitieren

APA

Sun, Z., Zhang, M., Ye, Y., & Yang, L. (2024). Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway. Hormone and Metabolic Research, 56(05), 381-391. https://doi.org/10.1055/a-2233-0245

Vancouver

Sun Z, Zhang M, Ye Y, Yang L. Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway. Hormone and Metabolic Research. 2024;56(05):381-391. doi:10.1055/a-2233-0245

BibTeX
@article{Sun2024,
  author = {Sun, Zhijun and Zhang, Min and Ye, Yangmei and Yang, Leilei},
  title = {Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway},
  journal = {Hormone and Metabolic Research},
  year = {2024},
  volume = {56},
  number = {05},
  pages = {381--391},
  doi = {10.1055/a-2233-0245}
}
Kostenlos starten →